Jefferies analyst Andrew Tsai downgraded Vistagen (VTGN) to Hold from Buy with a price target of 90c, down from $15.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VTGN:
- Vistagen downgraded to Hold from Buy at Maxim
- Vistagen downgraded to Market Perform from Outperform at William Blair
- Vistagen downgraded to Market Perform at William Blair after PALISADE-3 miss
- Vistagen downgraded to Hold at Stifel after PALISADE-3 study disappoints
- Vistagen downgraded to Hold from Buy at Stifel